[go: up one dir, main page]

AU2001290685A1 - Methods for inhibiting inflammatory disease - Google Patents

Methods for inhibiting inflammatory disease

Info

Publication number
AU2001290685A1
AU2001290685A1 AU2001290685A AU9068501A AU2001290685A1 AU 2001290685 A1 AU2001290685 A1 AU 2001290685A1 AU 2001290685 A AU2001290685 A AU 2001290685A AU 9068501 A AU9068501 A AU 9068501A AU 2001290685 A1 AU2001290685 A1 AU 2001290685A1
Authority
AU
Australia
Prior art keywords
methods
inflammatory disease
inhibiting inflammatory
inhibiting
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001290685A
Inventor
Charles Hiebert
Keith R. Laderoute
Daniel Tuse
Nahid Waleh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SRI International Inc
Large Scale Biology Corp
Original Assignee
SRI International Inc
Large Scale Biology Corp
Stanford Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SRI International Inc, Large Scale Biology Corp, Stanford Research Institute filed Critical SRI International Inc
Publication of AU2001290685A1 publication Critical patent/AU2001290685A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001290685A 2000-09-06 2001-09-06 Methods for inhibiting inflammatory disease Abandoned AU2001290685A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/656,144 US6433012B1 (en) 1998-03-25 2000-09-06 Method for inhibiting inflammatory disease
US09656144 2000-09-06
PCT/US2001/028155 WO2002020004A1 (en) 2000-09-06 2001-09-06 Methods for inhibiting inflammatory disease

Publications (1)

Publication Number Publication Date
AU2001290685A1 true AU2001290685A1 (en) 2002-03-22

Family

ID=24631819

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001290685A Abandoned AU2001290685A1 (en) 2000-09-06 2001-09-06 Methods for inhibiting inflammatory disease

Country Status (3)

Country Link
US (1) US6433012B1 (en)
AU (1) AU2001290685A1 (en)
WO (1) WO2002020004A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875165B2 (en) 2001-02-22 2005-04-05 Retinalabs, Inc. Method of radiation delivery to the eye
GB0225548D0 (en) 2002-11-01 2002-12-11 Glaxo Group Ltd Compounds
EP2336318B1 (en) 2002-11-13 2013-04-24 Genzyme Corporation Antisense modulation of apolipoprotein b expression
EP2336319A1 (en) 2002-11-13 2011-06-22 Genzyme Corporation Antisense modulation of apolipoprotein B expression
EP1720608B1 (en) 2004-02-12 2010-11-17 NeoVista, Inc. Apparatus for intraocular brachytherapy
US7563222B2 (en) 2004-02-12 2009-07-21 Neovista, Inc. Methods and apparatus for intraocular brachytherapy
WO2006023312A2 (en) * 2004-08-20 2006-03-02 Carl Deirmengian Diagnostic assay for source of inflammation
US20080119367A1 (en) * 2004-12-17 2008-05-22 Mayo Foundation For Medical Education And Research Prognosis of Renal Cell Carcinoma
EP1951372A4 (en) 2005-11-15 2011-06-22 Neovista Inc Methods and apparatus for intraocular brachytherapy
GB0622688D0 (en) * 2006-11-14 2006-12-27 Diosamine Dev Corp Novel compounds
US7850382B2 (en) 2007-01-18 2010-12-14 Sanford, L.P. Valve made from two materials and writing utensil with retractable tip incorporating same
US7488130B2 (en) 2007-02-01 2009-02-10 Sanford, L.P. Seal assembly for retractable instrument
EP2219451B1 (en) 2007-11-21 2014-11-12 Oxigene, Inc. Method for treating hematopoietic neoplasms
US8226312B2 (en) 2008-03-28 2012-07-24 Sanford, L.P. Valve door having a force directing component and retractable instruments comprising same
AU2009256236A1 (en) 2008-06-04 2009-12-10 Neovista, Inc. Handheld radiation delivery system for advancing a radiation source wire
US8221012B2 (en) 2008-11-07 2012-07-17 Sanford, L.P. Retractable instruments comprising a one-piece valve door actuating assembly
US8393814B2 (en) 2009-01-30 2013-03-12 Sanford, L.P. Retractable instrument having a two stage protraction/retraction sequence
WO2013112216A1 (en) 2012-01-24 2013-08-01 Cd Diagnostics, Llc System for detecting infection in synovial fluid
US9353150B2 (en) 2012-12-04 2016-05-31 Massachusetts Institute Of Technology Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment
WO2014144715A1 (en) 2013-03-15 2014-09-18 Memorial Sloan-Kettering Cancer Center Hsp90-targeted cardiac imaging and therapy
WO2016033424A1 (en) 2014-08-29 2016-03-03 Genzyme Corporation Methods for the prevention and treatment of major adverse cardiovascular events using compounds that modulate apolipoprotein b
JP2018523712A (en) 2015-08-18 2018-08-23 マテオン セラピューティクス, インク.Mateon Therapeutics, Inc. Use of VDAS to improve immunomodulatory therapy against tumors
US10918627B2 (en) 2016-05-11 2021-02-16 Massachusetts Institute Of Technology Convergent and enantioselective total synthesis of Communesin analogs
WO2018209239A1 (en) 2017-05-11 2018-11-15 Massachusetts Institute Of Technology Potent agelastatin derivatives as modulators for cancer invasion and metastasis
US10640508B2 (en) 2017-10-13 2020-05-05 Massachusetts Institute Of Technology Diazene directed modular synthesis of compounds with quaternary carbon centers
US11535634B2 (en) 2019-06-05 2022-12-27 Massachusetts Institute Of Technology Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof
WO2022182415A1 (en) 2021-02-24 2022-09-01 Massachusetts Institute Of Technology Himastatin derivatives, and processes of preparation thereof, and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001116A (en) * 1982-12-20 1991-03-19 The Children's Medical Center Corporation Inhibition of angiogenesis
US4994443A (en) * 1982-12-20 1991-02-19 The Children's Medical Center Corporation Inhibition of angiogenesis
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
EP0758390B1 (en) * 1994-04-26 2007-02-28 The Children's Medical Center Corporation Angiostatin and method of use for inhibition of angiogenesis
US5583153A (en) * 1994-10-06 1996-12-10 Regents Of The University Of California Use of taxol in the treatment of rheumatoid arthritis
US5736576A (en) * 1996-06-04 1998-04-07 Octamer, Inc. Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity
US6017958A (en) * 1996-06-04 2000-01-25 Octamer, Inc. Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity
AU741382B2 (en) * 1997-03-26 2001-11-29 Large Scale Biology Corporation Di-aryl ethers and their derivatives as anti-cancer agents
US5922775A (en) * 1997-10-23 1999-07-13 Octamer, Inc. Method of treating malignant tumors with ketone thyroxine analogues having no significant hormonal activity

Also Published As

Publication number Publication date
US6433012B1 (en) 2002-08-13
WO2002020004A1 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
AU2001290685A1 (en) Methods for inhibiting inflammatory disease
AU2001288271A1 (en) Methods for treating inflammatory diseases
AU2001258771A1 (en) -secretase inhibitors
HUP0303622A3 (en) Emedies for inflammatory bowel diseases
AU2000267458A1 (en) Hypercomputer
AU2001254546A1 (en) Aminopiperidines
AU2001220246A1 (en) Neckphone
EP1215910A3 (en) Watermarking
AUPQ661800A0 (en) Insulin-potentiating compounds
AU2001263909A1 (en) Diphenylmethane derivatives
AU2001227953A1 (en) Methods for raising rabbits
AU5256301A (en) Froindazole derivative
AU2001258255A1 (en) Substituted benzoylcyclohexenones
AU2001265871A1 (en) Substituted sulfonylaminopyrimidines
AU2608301A (en) Methods for inhibiting mastocytosis
AU2001220281A1 (en) Rollerboard for road-skiing
AU2001254731A1 (en) Substituted phenyluracils
AU2002225724A1 (en) Motilide compounds
AU2001266176A1 (en) Methods
AU2002217285A1 (en) Compounds
AU2001246864A1 (en) Hypotensors
AU2002223604A1 (en) Substituted phenyluracils
AU2001282770A1 (en) Trap
AU2001250536A1 (en) Methods
AU2002220757A1 (en) Method for obtaining azaerythromycin